Treatment of Crohn's disease with laquinimod
US8598203B2 · kind B2 · utility
65Cited by
21References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 29, 2010 |
| Grant date | Dec 3, 2013 |
| Priority date | — |
| Expiry date | Jun 8, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D215/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This application provides for a method of treating a subject suffering from Crohn's disease, the method comprising periodically administering to the subject an amount of laquinimod or pharmaceutically acceptable salt thereof effective to treat the subject. This application provides for use of laquinimod in the manufacture of a medicament for treating a subject suffering from Crohn's disease. This application also provides for a pharmaceutical composition comprising laquinimod for use in treating a subject suffering from Crohn's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.